These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2428168)

  • 1. The cellular tumour antigen p53: evidence for transformation-related, immunological variants of p53.
    Milner J; Cook A
    Virology; 1986 Oct; 154(1):21-30. PubMed ID: 2428168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that immunological variants of p53 represent alternative protein conformations.
    Gamble J; Milner J
    Virology; 1988 Feb; 162(2):452-8. PubMed ID: 2448954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody analysis of p53 expression in normal and transformed cells.
    Yewdell JW; Gannon JV; Lane DP
    J Virol; 1986 Aug; 59(2):444-52. PubMed ID: 2426467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in antigenic determinants of p53 transformation-related protein obtained from various species.
    Rotter V; Friedman H; Katz A; Zerivitz K; Wolf D
    J Immunol; 1983 Jul; 131(1):329-33. PubMed ID: 6190914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule.
    Wolf D; Harris N; Goldfinger N; Rotter V
    Mol Cell Biol; 1985 Jan; 5(1):127-32. PubMed ID: 2580227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologically distinct p53 molecules generated by alternative splicing.
    Arai N; Nomura D; Yokota K; Wolf D; Brill E; Shohat O; Rotter V
    Mol Cell Biol; 1986 Sep; 6(9):3232-9. PubMed ID: 3023970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein.
    Milner J; Watson JV
    Oncogene; 1990 Nov; 5(11):1683-90. PubMed ID: 2176282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two immunologically differing forms of p53 oncoprotein from B-lymphocytes of mice are coded with identical mRNA].
    Chumakov PM; Jenkins JR; Milner R
    Mol Gen Mikrobiol Virusol; 1989 Aug; (8):14-6. PubMed ID: 2478880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the in vitro interaction between SV40 T antigen and p53: mapping the p53 binding site.
    Schmieg FI; Simmons DT
    Virology; 1988 May; 164(1):132-40. PubMed ID: 2834865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for allosteric variants of wild-type p53, a tumour suppressor protein.
    Cook A; Milner J
    Br J Cancer; 1990 Apr; 61(4):548-52. PubMed ID: 2139577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transformation-related p53 protein: a potential regulator of cell proliferation.
    Mercer WE; Baserga R
    Prog Clin Biol Res; 1985; 177():171-91. PubMed ID: 2409558
    [No Abstract]   [Full Text] [Related]  

  • 12. Visualisation, by immunocytochemistry, of p53 at the plasma membrane of both nontransformed and SV40-transformed cells.
    Milner J; Cook A
    Virology; 1986 Apr; 150(1):265-9. PubMed ID: 3006339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein.
    Crawford LV; Pim DC; Gurney EG; Goodfellow P; Taylor-Papadimitriou J
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):41-5. PubMed ID: 6264441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precise epitope mapping of the murine transformation-associated protein, p53.
    Wade-Evans A; Jenkins JR
    EMBO J; 1985 Mar; 4(3):699-706. PubMed ID: 2408882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells.
    Reihsaus E; Kohler M; Kraiss S; Oren M; Montenarh M
    Oncogene; 1990 Jan; 5(1):137-45. PubMed ID: 2157179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human p53 antigens employing primate specific monoclonal antibodies.
    Thomas R; Kaplan L; Reich N; Lane DP; Levine AJ
    Virology; 1983 Dec; 131(2):502-17. PubMed ID: 6318442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in distribution and content of p53 in SV40-transformed mouse fibroblasts.
    Davis D; Wynford-Thomas D
    Exp Cell Res; 1986 Sep; 166(1):94-102. PubMed ID: 3017740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation by simian virus 40 does not involve the mutational activation of p53 to an oncogenic form.
    Lin JY; Simmons DT
    Virology; 1990 May; 176(1):302-5. PubMed ID: 2158695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.
    Olson DC; Marechal V; Momand J; Chen J; Romocki C; Levine AJ
    Oncogene; 1993 Sep; 8(9):2353-60. PubMed ID: 7689721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40.
    Milner J; Cook A; Sheldon M
    Oncogene; 1987; 1(4):453-5. PubMed ID: 3330789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.